Yuancan Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuancan Pan has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Gan-Lin Zhang
Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China
2 shared publications Haiming Li
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China
2 shared publicationsXiaohui Yin
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China
2 shared publications- Xiaomin Wang
Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China
2 shared publications Yue Wang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China
2 shared publicationsYutong Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China
2 shared publications
Latest Publications
- 25 December 2023
- Published by Wolters Kluwer Health in Hepatology
- Vol. 79 (4) , E123-E124
Letter to the Editor: The Hepa 1–6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy
An abstract is unavailable. This article is available as a PDF only.
- 25 December 2023
- Published by Wolters Kluwer Health in Hepatology
- Vol. 79 (4) , E123-E124
Letter to the Editor: The Hepa 1–6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy
An abstract is unavailable. This article is available as a PDF only.
- 26 November 2022
- Published by Elsevier in Journal of Infection
- Vol. 86 (2) , 154-225
Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: A systematic review and meta-analysis of 16 cohort studies
- 26 November 2022
- Published by Elsevier in Journal of Infection
- Vol. 86 (2) , 154-225
Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: A systematic review and meta-analysis of 16 cohort studies